Please login to the form below

The concordance conundrum: creating space for open dialogue

Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in treatment concordance. However, achieving this delicate equilibrium does require the pharma industry to support HCPs to do their job more effectively when interacting with patients. So how can industry help?

Patients are almost unrecognisable today compared to 10 or 20 years ago when healthcare professionals (HCPs) often viewed patients as compliant, obedient and uninformed. Today’s patient is informed and has an opinion on what their potential diagnosis might be, and which tests and treatment options are available.

There is still and always will be a degree of inequity in the relationship because no matter how well-informed patients believe they are, they didn’t study for seven plus years and their source of information may not be trustworthy. Nonetheless, the dynamic between the parties has shifted and HCPs, with support from industry, need to be better equipped to answer probing questions about their choice of treatment and its likely side effects.

Arguably, in eagerly moving away from the paternalistic model of old, the pendulum has swung too far (there will be advocates and naysayers for both) in favour of an information-led relationship. The shared decision-making agenda aims at integrating these extremes in an atmosphere of respect (from both parties), cooperation and trust – a cooperative-deliberative model.

With the ‘excellence-of-the-product-is-all-that-matters’ era a thing of the past, the focus now is on experience and building trust across the industry-HCP-patient relationship continuum.

By opening up and rebalancing the discussion around medication, the consultation is likely to be more satisfying for all parties and, therefore, more effective with the patient having a true understanding of the importance of treatment concordance and the implications of non-concordance. This is not a guarantee that they will concord, but it is a step in the right direction.

Sounds obvious? It may well be but given that models to improve the HCP-patient dynamic date back to 1989, and we are still talking about it now, it seems there is still plenty of room for improvement.

In 2016, the Agency of Healthcare Research and Quality developed the SHARE Approach – a five-step process to open up dialogue between HCPs and patients.

Alongside this, it is important to gain an understanding of how this process can aid concordance.There are five pre-requisites for concordance in consultations:2

  1. A willingness to share power and a commitment to giving appropriate weight to patient values and goals
  2. Open discussion of the option, specifically to gain understanding of the patient’s views without making assumptions
  3. Adequate sharing of information including the uncertainties taken into consideration in arriving at the current decision
  4. Listening as much, if not more so, than talking
  5. Time – with a short amount of time available it is important that the patient does not feel hurried.

Barriers to a cooperative-deliberative model

For some this will still seem aspirational and difficult to achieve. There is a natural imbalance in the relationship in relative terms based on knowledge, which can elicit a raft of emotions from ‘hero’ complex at one end and inferiority at the other (underpinned by arrogance and confirmation basis; fear and uncertainty, respectively).

Not all patients are ready for shared decision-making – some still prefer a clinician-led approach but increasing numbers want partnership.

There is a middle ground, but it requires greater imagination and empathy, open-mindedness and the ability to listen actively; a true understanding that the quality of the communication is the responsibility of the communicator and not the recipient.

The role of industry

A move to this model is also reliant on changing the dynamic between the pharma industry and HCPs. A plethora of information exists for HCPs, but it is built around what the industry wants to say about its products and less around supporting HCPs to do their job more effectively in terms of increasing concordance.

A move to this model is also reliant on changing the dynamic between the pharma industry and HCPs.  A plethora of information exists for HCPs, but it is built around what the industry wants to say  about its products and less around supporting  HCPs to do their job more effectively in terms of increasing concordance.

If shared decision-making is to succeed as a means of increasing self-care, releasing time back to care and reducing cost pressures on health services, we need to change from a push to a pull model: one where HCPs are initiating the conversation around what information and tools they need from pharma to develop and maintain meaningful relationships with patients.

There is a need to ea need to educate HCPs and patients across a mix of channels, enabling them to have more meaningful conversations. Evidence suggests that an integrated media approach is the best way to deliver trusted and meaningful education that should be modular, flexible and quick and easy to find.

Find out more

The HCP–patient dynamic is one of a series of articles focused on how companies can make the most of these opportunities, exploring how communication between industry and HCPs, and between HCPs and their patients can be taken to the next level to improve patient outcomes.

To find out more and to download other articles in the series visit pageandpage.uk.com/media_lab

30th September 2020

Share

Tags

Company Details

Page & Page and Partners

+44 (0)20 8617 8250

Contact Website

Address:
76 Calverley Road
Tubridge Wells
Kent
TN1 2UJ
United Kingdom

Latest content on this profile

Senior team at Page & Page become Partners
Page & Page and Partners are announcing the appointment of their senior management team to partners in the agency. The new partners will be actively involved in shaping the future of the business as well as having a financial stake in its future.
Page & Page and Partners
The concordance conundrum: the art of active listening
The art of active listening explores the links between effective communication and better patient concordance and medical outcomes, why many HCPs still overestimate their ability to communicate effectively and the opportunity this presents to industry to better support HCPs in this role.
Page & Page and Partners
The concordance conundrum: understanding the complexities of behaviour change
Understanding behaviour change looks at the six fundamental steps required to change human behaviour and discusses why HCPs need to start here if concordance is to be improved.
Page & Page and Partners
The concordance conundrum: creating space for open dialogue
Growing numbers of patients want a partnership model with their HCP, whereby both parties are equally involved in the decision-making process. This model has been linked with an increase in treatment concordance. However, achieving this delicate equilibrium does require the pharma industry to support HCPs to do their job more effectively when interacting with patients. So how can industry help?
Page & Page and Partners
The concordance conundrum: the tech divide
COVID-19 resulted in the rapid adoption of virtual consultations; while they offer increased accessibility and convenience for some, are they really all they are cracked up to be? Consultations in a virtual world explores the pros and cons of virtual consultations and the responsibilities that the private sector and tech community should address with regards to ensuring that the poorest and most vulnerable in society don’t get forgotten or left behind in a seemingly more digital world.
Page & Page and Partners
Improving patient concordance: where does industry fit in?
What’s in a name? explores the idea that those healthcare organisations that develop tools and support structures to improve concordance will be at an advantage when it comes to product procurement from HCPs in the future.
Page & Page and Partners